Trial Condition(s):

Respiratory Tract Infections

Efficacy and Safety of Ciprofloxacin in the Treatment of Patients with Respiratory Tract Infections

Bayer Identifier:

Trial_0338

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

EU CT Number:

Not Available

Study Completed

Trial Purpose

Please see attached Study Results Summary below.

Inclusion Criteria

No Inclusion Criteria Available

Exclusion Criteria

No Exclusion Criteria Available

Trial Summary

Enrollment Goal

Trial Dates

January1984

December1984

Phase

N/A

Could I receive a placebo?

Products

Cipro (Ciprofloxacin hydrochloride, BAYO9867)

Accepts Healthy Volunteers

N/A

Where to Participate

Locations

Status

Locations	Status

Respiratory Tract Infections

Bayer Identifier:

ClinicalTrials.gov Identifier:

EudraCT Number:

EU CT Number:

Trial Purpose

Key Participation Requirements

sex

age

16 Years

79 Years

Inclusion Criteria

Exclusion Criteria

Inclusion Criteria

Exclusion Criteria

Trial Summary

Enrollment Goal

Trial Dates

Phase

Could I receive a placebo?

Products

Accepts Healthy Volunteers

Where to Participate

For details, please refer to trial results

Additional Information